 |
 |
|
TIDES® 2009
寡核酸(oligonucleotide)与胜肽(peptide)相关之技术与制品开发
2009年5月17～20日
华达州．拉斯维加斯．Red Rock Resort and Spa
|
|
语言选择
|
|
邀请演讲
|
 |
Not Just a Message: Noncoding RNAs in Biology and Medicine
Thomas R. Cech, Ph.D.
Distinguished Professor, University of Colorado-Boulder;
Nobel Laureate, 1989 (Chemistry)
Sponsored by 
|
|
基调讲演
 |
Human Genetics and Oligonucleotides: Essential Partners in Pharma's Future
Arthur M. Krieg, M.D.
Chief Scientific Officer, Research Technology Center, Pfizer Inc
|
 |
Peptide Therapeutics: Trends in Global Clinical Development and Approval
Janice M. Reichert, Ph.D.
Senior Research Fellow, Tufts Center for the Study of Drug Development; Editor-in-Chief, mAbs, Landes Bioscience
|
 |
Therapeutic Strategies Using RNA Interference
John J. Rossi, Ph.D
Lidow Family Research Chair, Professor, Division of Molecular Biology; Dean, Graduate School of Biological Sciences; Beckman Research Institute of City of Hope
|
 |
Taking Advantage of Peptide Aggregation
Joel P. Schneider, Ph.D.
Associate Professor, Department of Chemistry and Biochemistry, Department of Materials Science and Engineering, University of Delaware
|
 |
"The TIDES Conference is an invaluable resource to anyone working in the sphere of drug delivery and peptides. The breadth of topics and depth of expertise is extremely impressive."
Gary Riley, D.V.M., Ph.D., Vice-President, Nonclinical Development and Applied Biology, Emisphere Technologies
"This meeting is an assembly of the top investigators in both academics and industry in the field of oligos and peptides."
Joseph Sinkule, Pharm.D., Founder, Director and CSO, Apthera, Inc.
"Excellent summit covering recent progress in oligonucleotide therapeutics."
Anastasia Khvorova, Ph.D., CSO, RXi Pharmaceuticals Corporation
"A unique conference that brings together the many aspects of the Molecular Diagnostics industry."
Nancy Schoenbrunner, Ph.D., Research Leader, Program in Core Research, Roche Molecular Systems, Inc.
- 法规战略: Lilly、Avecia OligoMedicines、OncoGenex、Ipsen、Millennium及Pfizer之案例学习中，对于了解降低经济与法规上之风险将有所助益。
- 新技术注目焦点: 寡核酸与胜肽相关2个半天的议程
- 新化学专利的机会与未来的制造市场需求之确认
- 具市场扩大潜力之传递技术
- 改善寡核酸与胜肽制品品质与产量之喷雾乾燥
- 以苯并三唑(benzotriazole)为基之偶合剂的非爆炸性替代品
- 改善microRNA标靶之立体块状寡核酸及其胜肽结合技术
- 提升制造效率之固态及液态合成技术
- 错体分子之分析技术
- 改善特定化与品质管理相关之Merck、Bristol-Myers、华盛顿大学、Regado、Alnylam及Isis的技术战略与法规战略
- 涵盖从传递、临床前期、到临床开发中，主要候选药剂最新动向之2个全天的议程
- microRNA、siRNA、LNA、标靶传递、SNALP、适性体(aptamers)、1日1回之GLP-1类似物、吸入型肥胖治疗用胜肽、PEG替代品、补体抑制剂(complement inhibitors)、pepducin、Ipsen-Roche等与GLP-1analogues、Linaclotide、胜肽co-polymer之合作
New Added Benefits to Attending in 2009!
- 最新投资及合作机会之创新展示
- 面对最紧急课题所进行之未审查策略讨论论坛
- 品质保证、RNA制造、生物分析技术相关详情
- 胜肽与寡核酸管理分析开发及品质管理之订制课程
|
|
|
TIDES® registration also includes access to IBC's 5th International
Applications of Nucleic Acids Technologies in Molecular Diagnostics
Accelerating Product Development through Cutting Edge Regulatory, Business and Technology Strategies
May 19-20, 2009 · Red Rock Casino, Resort & Spa · Las Vegas, NV
Keynote Presentations
 |
|
Molecular Diagnostics: Revolution, Regulation and Reimbursement
Alberto Gutierrez, Ph.D.
Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety
CDRH, US FDA
|
|
 |
|
Molecular Diagnostics: A Key Component of the Future Healthcare Value Chain
George Poste, D.V.M., Ph.D.
Director, The Biodesign Institute
Arizona State University
|
|
 |
|
Reagent Solutions to Challenges in Oligonucleotide Diagnostics
Steven A. Benner, Ph.D.
Distinguished Fellow
Foundation for Applied Molecular Evolution Inc.
|
|
|
